Charles J - Search Results

1

Mesalazine and para-phenylenediamine allergy.

Charles J, Bourrain JL, Tessier A, Lepoittevin JP, Beani JC. Charles J, et al. Contact Dermatitis. 2004 Nov-Dec;51(5-6):313-4. doi: 10.1111/j.0105-1873.2004.0459d.x. Contact Dermatitis. 2004. PMID: 15606661 No abstract available.

2

[Syringotropic and pilotropic cutaneous T-cell lymphoma without follicular mucinosis].

Charles J, Lantuejoul S, Reymond JL, Cuchet E, Wechsler J, Béani JC. Charles J, et al. Ann Dermatol Venereol. 2007 Feb;134(2):155-9. doi: 10.1016/s0151-9638(07)91609-9. Ann Dermatol Venereol. 2007. PMID: 17375013 French.

3

Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer.

Charles J, Chaperot L, Salameire D, Di Domizio J, Aspord C, Gressin R, Jacob MC, Richard MJ, Beani JC, Plumas J, Leccia MT. Charles J, et al. Eur J Dermatol. 2010 Jan-Feb;20(1):16-23. doi: 10.1684/ejd.2010.0816. Epub 2009 Oct 22. Eur J Dermatol. 2010. PMID: 19850548 Free PMC article. Review.

4

Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients.

Epaulard O, Saint-Raymond C, Villier C, Charles J, Roch N, Beani JC, Leccia MT. Epaulard O, et al. Among authors: charles j. Clin Microbiol Infect. 2010 Sep;16(9):1362-4. doi: 10.1111/j.1469-0691.2009.03124.x. Clin Microbiol Infect. 2010. PMID: 19930272 Free article.

5

Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation.

Charles J, Beani JC, Fiandrino G, Busser B. Charles J, et al. J Am Acad Dermatol. 2014 Sep;71(3):e97-9. doi: 10.1016/j.jaad.2014.03.038. J Am Acad Dermatol. 2014. PMID: 25128147 Free article. No abstract available.

6

Access to molecular guided therapy for Langerhans cell histiocytosis patients.

Charles J, Beani JC, Tardieu M, Busser B. Charles J, et al. J Am Acad Dermatol. 2015 Jul;73(1):e31. doi: 10.1016/j.jaad.2015.03.007. J Am Acad Dermatol. 2015. PMID: 26089071 No abstract available.

7

Fixed drug eruption caused by fulvestrant confirmed by skin tests: First case.

Broche C, Pralong P, Gil H, Yahiaoui N, Mousseau M, Chatain C, Jacquier JP, Charles J, Leccia MT. Broche C, et al. Among authors: charles j. Contact Dermatitis. 2019 Mar;80(3):184-186. doi: 10.1111/cod.13161. Epub 2018 Nov 21. Contact Dermatitis. 2019. PMID: 30461027 No abstract available.

8

Contribution of phototesting in the diagnosis of photodermatoses: Retrospective study of 100 cases.

Pralong P, Ciszynski M, Moncourier M, Beani JC, Charles J, Leccia MT. Pralong P, et al. Among authors: charles j. Photodermatol Photoimmunol Photomed. 2022 Mar;38(2):99-103. doi: 10.1111/phpp.12721. Epub 2021 Aug 5. Photodermatol Photoimmunol Photomed. 2022. PMID: 34328236

9

[Acantholytic dermatosis in patients treated by vemurafenib: 2 cases].

Sabatier-Vincent M, Charles J, Pinel N, Challende I, Claeys A, Leccia MT. Sabatier-Vincent M, et al. Among authors: charles j. Ann Dermatol Venereol. 2014 Nov;141(11):689-93. doi: 10.1016/j.annder.2014.09.024. Epub 2014 Oct 23. Ann Dermatol Venereol. 2014. PMID: 25442474 French.

10

[CDKN2A gene mutation and loss of p16 protein activity in a patient on levodopa presenting sporadic multiple primary melanoma].

Templier I, Charles J, Combe MC, Bressac de Paillerets B, Leroux D, Leccia MT. Templier I, et al. Among authors: charles j. Ann Dermatol Venereol. 2006 Oct;133(10):777-80. doi: 10.1016/s0151-9638(06)71042-0. Ann Dermatol Venereol. 2006. PMID: 17072193 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,131 results

Search Page